🔎 Trials Near Me

Beranda › Limfoma Sel B Besar Difus › California › Baldwin Park

Uji klinis Limfoma Sel B Besar Difus di Baldwin Park, CA

19 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Menerima pesertaFase 2
  • City of Hope, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06500273

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Menerima pesertaFase 2
  • City of Hope Comprehensive Cancer Center ( Site 0191), Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06890884

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Menerima pesertaFase 1
  • City of Hope, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Menerima pesertaFase 1
  • City of Hope, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07101328

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Menerima pesertaFase 1
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07195916

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Menerima pesertaFase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05272384

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 2
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07365306

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Menerima pesertaFase 1/2
  • City of Hope, Duarte · 4 mi jauhnya
Usia 13 hingga 90 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06533579

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05077527

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 2
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05672251

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06015880

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • City of Hope, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05131022

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Menerima pesertaFase 1/2
  • City of Hope, Duarte · 4 mi jauhnya
Usia 12 hingga 95 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • City of Hope, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT04830137

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

Menerima pesertaFase 2
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT07042438

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05432635

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Menerima pesertaFase awal 1
  • City of Hope Medical Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT05800405

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Menerima pesertaFase 2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT05890352

Uji klinis Limfoma Sel B Besar Difus di kota lain

Studi lain di Baldwin Park

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.